| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 7.17e-07 | 6 | 67 | 3 | GO:0015277 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.15e-05 | 100 | 67 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 2.37e-05 | 17 | 67 | 3 | GO:0004970 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.78e-05 | 52 | 67 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 2.84e-05 | 18 | 67 | 3 | GO:0015280 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 6.72e-05 | 65 | 67 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 6.72e-05 | 65 | 67 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 6.95e-05 | 24 | 67 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 9.97e-05 | 27 | 67 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.18e-04 | 75 | 67 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.30e-04 | 77 | 67 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 2.30e-04 | 7 | 67 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 3.03e-04 | 39 | 67 | 3 | GO:0030551 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 3.17e-04 | 97 | 67 | 4 | GO:0008081 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase inhibitor activity | 4.05e-04 | 43 | 67 | 3 | GO:0004869 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines | 5.98e-04 | 11 | 67 | 2 | GO:0016813 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 6.67e-04 | 118 | 67 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 9.28e-04 | 57 | 67 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.08e-03 | 60 | 67 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.64e-03 | 18 | 67 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.68e-03 | 70 | 67 | 3 | GO:0003777 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.62e-03 | 171 | 67 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 3.15e-03 | 180 | 67 | 4 | GO:0004866 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 3.42e-03 | 26 | 67 | 2 | GO:0004435 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 3.59e-03 | 441 | 67 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 3.61e-03 | 187 | 67 | 4 | GO:0030414 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 3.69e-03 | 27 | 67 | 2 | GO:0004112 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.96e-03 | 28 | 67 | 2 | GO:0051959 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 4.03e-03 | 193 | 67 | 4 | GO:0015276 | |
| GeneOntologyMolecularFunction | phospholipase C activity | 4.25e-03 | 29 | 67 | 2 | GO:0004629 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 4.34e-03 | 197 | 67 | 4 | GO:0022834 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 4.37e-03 | 459 | 67 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 4.43e-03 | 614 | 67 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 4.66e-03 | 201 | 67 | 4 | GO:0061135 | |
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | 5.08e-03 | 206 | 67 | 4 | GO:0043021 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 5.17e-03 | 207 | 67 | 4 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 5.25e-03 | 208 | 67 | 4 | GO:0005342 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 5.30e-03 | 105 | 67 | 3 | GO:0015171 | |
| GeneOntologyMolecularFunction | phospholipase activity | 6.66e-03 | 114 | 67 | 3 | GO:0004620 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 6.85e-03 | 37 | 67 | 2 | GO:0045505 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | USP14 PTTG3P PTTG1 TIAM1 SRGAP1 MOB1A PLCB1 PRKAR2A RPGR ARHGAP21 PTTG2 | 7.20e-03 | 1418 | 67 | 11 | GO:0030234 |
| GeneOntologyBiologicalProcess | mitotic sister chromatid cohesion | 8.58e-08 | 36 | 64 | 5 | GO:0007064 | |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 1.48e-07 | 40 | 64 | 5 | GO:1990806 | |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 1.08e-06 | 59 | 64 | 5 | GO:0007215 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 1.40e-06 | 27 | 64 | 4 | GO:0035235 | |
| GeneOntologyBiologicalProcess | sister chromatid cohesion | 2.04e-06 | 67 | 64 | 5 | GO:0007062 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission, glutamatergic | 7.97e-06 | 13 | 64 | 3 | GO:0051967 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | GABRP USP14 DRD1 NALCN PLCB1 PRKAR2A GRIK1 SYNPO GRIK2 GRIK3 PLCL1 CNP | 2.50e-05 | 931 | 64 | 12 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | GABRP USP14 DRD1 NALCN PLCB1 PRKAR2A GRIK1 SYNPO GRIK2 GRIK3 PLCL1 CNP | 2.50e-05 | 931 | 64 | 12 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | GABRP USP14 DRD1 NALCN PLCB1 PRKAR2A GRIK1 SYNPO GRIK2 GRIK3 PLCL1 CNP | 2.72e-05 | 939 | 64 | 12 | GO:0099537 |
| GeneOntologyBiologicalProcess | synaptic signaling | GABRP USP14 DRD1 NALCN PLCB1 PRKAR2A GRIK1 SYNPO GRIK2 GRIK3 PLCL1 CNP | 3.97e-05 | 976 | 64 | 12 | GO:0099536 |
| GeneOntologyBiologicalProcess | homologous chromosome segregation | 1.01e-04 | 78 | 64 | 4 | GO:0045143 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 1.12e-04 | 80 | 64 | 4 | GO:0050805 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 1.81e-04 | 268 | 64 | 6 | GO:1903046 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 1.92e-04 | 92 | 64 | 4 | GO:0051966 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 1.97e-04 | 663 | 64 | 9 | GO:0050804 | |
| GeneOntologyBiologicalProcess | axon midline choice point recognition | 1.97e-04 | 7 | 64 | 2 | GO:0016199 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 1.99e-04 | 664 | 64 | 9 | GO:0099177 | |
| GeneOntologyBiologicalProcess | regulation of long-term neuronal synaptic plasticity | 2.59e-04 | 40 | 64 | 3 | GO:0048169 | |
| GeneOntologyBiologicalProcess | postsynaptic modulation of chemical synaptic transmission | 3.00e-04 | 42 | 64 | 3 | GO:0099170 | |
| GeneOntologyBiologicalProcess | modification of postsynaptic structure | 3.00e-04 | 42 | 64 | 3 | GO:0099010 | |
| GeneOntologyBiologicalProcess | axon choice point recognition | 3.36e-04 | 9 | 64 | 2 | GO:0016198 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, GABAergic | 3.68e-04 | 45 | 64 | 3 | GO:0032228 | |
| GeneOntologyBiologicalProcess | modification of synaptic structure | 5.34e-04 | 51 | 64 | 3 | GO:0099563 | |
| GeneOntologyBiologicalProcess | meiotic chromosome segregation | 5.63e-04 | 122 | 64 | 4 | GO:0045132 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | 7.49e-04 | 350 | 64 | 6 | GO:0051321 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 7.57e-04 | 132 | 64 | 4 | GO:0035249 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 5.97e-07 | 6 | 66 | 3 | GO:0032983 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 6.56e-07 | 317 | 66 | 9 | GO:0032838 | |
| GeneOntologyCellularComponent | cytoplasmic region | 1.88e-06 | 360 | 66 | 9 | GO:0099568 | |
| GeneOntologyCellularComponent | axoneme | 4.01e-06 | 207 | 66 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 4.13e-06 | 208 | 66 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | cilium | FSIP2 DNAH3 PTTG3P PTTG1 DRD1 TIAM1 VCAN DNAH2 PRKAR2A DNAI4 RPGR PTTG2 | 2.12e-05 | 898 | 66 | 12 | GO:0005929 |
| GeneOntologyCellularComponent | axonemal dynein complex | 6.58e-05 | 25 | 66 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.04e-04 | 29 | 66 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 3.88e-04 | 45 | 66 | 3 | GO:0008328 | |
| GeneOntologyCellularComponent | inner dynein arm | 4.35e-04 | 10 | 66 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 5.30e-04 | 50 | 66 | 3 | GO:0098878 | |
| GeneOntologyCellularComponent | axon terminus | 5.30e-04 | 210 | 66 | 5 | GO:0043679 | |
| GeneOntologyCellularComponent | dynein complex | 6.65e-04 | 54 | 66 | 3 | GO:0030286 | |
| GeneOntologyCellularComponent | perikaryon | 6.96e-04 | 223 | 66 | 5 | GO:0043204 | |
| GeneOntologyCellularComponent | neuron projection terminus | 8.47e-04 | 233 | 66 | 5 | GO:0044306 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 1.02e-03 | 817 | 66 | 9 | GO:0098978 | |
| GeneOntologyCellularComponent | supramolecular fiber | DNAH3 SYNPO2 TIAM1 DNAH2 DIAPH2 KIF14 MYH15 SYNPO CMYA5 CNP AHNAK2 | 1.08e-03 | 1179 | 66 | 11 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | DNAH3 SYNPO2 TIAM1 DNAH2 DIAPH2 KIF14 MYH15 SYNPO CMYA5 CNP AHNAK2 | 1.14e-03 | 1187 | 66 | 11 | GO:0099081 |
| GeneOntologyCellularComponent | neuronal cell body | 1.19e-03 | 835 | 66 | 9 | GO:0043025 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.22e-03 | 378 | 66 | 6 | GO:0034702 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.54e-03 | 157 | 66 | 4 | GO:0098839 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.69e-03 | 161 | 66 | 4 | GO:0005875 | |
| GeneOntologyCellularComponent | myofibril | 1.71e-03 | 273 | 66 | 5 | GO:0030016 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.74e-03 | 405 | 66 | 6 | GO:0045211 | |
| GeneOntologyCellularComponent | axon | 1.86e-03 | 891 | 66 | 9 | GO:0030424 | |
| GeneOntologyCellularComponent | costamere | 2.18e-03 | 22 | 66 | 2 | GO:0043034 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.22e-03 | 290 | 66 | 5 | GO:0043292 | |
| GeneOntologyCellularComponent | cell body | 2.48e-03 | 929 | 66 | 9 | GO:0044297 | |
| GeneOntologyCellularComponent | distal axon | 2.49e-03 | 435 | 66 | 6 | GO:0150034 | |
| GeneOntologyCellularComponent | postsynaptic density | 2.97e-03 | 451 | 66 | 6 | GO:0014069 | |
| GeneOntologyCellularComponent | non-motile cilium | 3.43e-03 | 196 | 66 | 4 | GO:0097730 | |
| GeneOntologyCellularComponent | terminal bouton | 3.48e-03 | 96 | 66 | 3 | GO:0043195 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 3.76e-03 | 201 | 66 | 4 | GO:0099634 | |
| GeneOntologyCellularComponent | asymmetric synapse | 3.91e-03 | 477 | 66 | 6 | GO:0032279 | |
| GeneOntologyCellularComponent | potassium channel complex | 4.36e-03 | 104 | 66 | 3 | GO:0034705 | |
| GeneOntologyCellularComponent | postsynapse | 4.54e-03 | 1018 | 66 | 9 | GO:0098794 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 5.06e-03 | 503 | 66 | 6 | GO:0099572 | |
| GeneOntologyCellularComponent | motile cilium | 5.26e-03 | 355 | 66 | 5 | GO:0031514 | |
| GeneOntologyCellularComponent | Flemming body | 5.77e-03 | 36 | 66 | 2 | GO:0090543 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 6.09e-03 | 523 | 66 | 6 | GO:0098984 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 6.09e-03 | 523 | 66 | 6 | GO:1902495 | |
| GeneOntologyCellularComponent | dendrite cytoplasm | 6.75e-03 | 39 | 66 | 2 | GO:0032839 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 6.80e-03 | 238 | 66 | 4 | GO:0097729 | |
| GeneOntologyCellularComponent | transporter complex | 7.73e-03 | 550 | 66 | 6 | GO:1990351 | |
| GeneOntologyCellularComponent | sarcomere | 7.95e-03 | 249 | 66 | 4 | GO:0030017 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 9.58e-03 | 576 | 66 | 6 | GO:0015629 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.01e-02 | 583 | 66 | 6 | GO:0097060 | |
| MousePheno | absent sperm fibrous sheath | 3.55e-06 | 8 | 57 | 3 | MP:0030591 | |
| MousePheno | decreased pancreatic beta cell proliferation | 1.04e-05 | 11 | 57 | 3 | MP:0011820 | |
| MousePheno | polyuria | 3.01e-05 | 89 | 57 | 5 | MP:0001762 | |
| MousePheno | abnormal pancreatic beta cell proliferation | 8.11e-05 | 21 | 57 | 3 | MP:0011818 | |
| MousePheno | decreased paired-pulse facilitation | 1.39e-04 | 25 | 57 | 3 | MP:0002920 | |
| MousePheno | reduced long-term potentiation | 2.67e-04 | 141 | 57 | 5 | MP:0001473 | |
| MousePheno | abnormal long-term potentiation | 2.70e-04 | 221 | 57 | 6 | MP:0002207 | |
| MousePheno | abnormal sperm fibrous sheath morphology | 2.93e-04 | 32 | 57 | 3 | MP:0030590 | |
| MousePheno | decreased pancreatic beta cell mass | 2.93e-04 | 32 | 57 | 3 | MP:0009114 | |
| MousePheno | abnormal urination | 3.34e-04 | 148 | 57 | 5 | MP:0001756 | |
| MousePheno | thymus hyperplasia | 3.52e-04 | 34 | 57 | 3 | MP:0000708 | |
| Domain | ANF_lig-bd_rcpt | 7.61e-06 | 37 | 64 | 4 | IPR001828 | |
| Domain | ANF_receptor | 7.61e-06 | 37 | 64 | 4 | PF01094 | |
| Domain | Peripla_BP_I | 9.42e-06 | 39 | 64 | 4 | IPR028082 | |
| Domain | Securin_separation-inh_met | 1.16e-05 | 2 | 64 | 2 | IPR018008 | |
| Domain | Securin | 1.16e-05 | 2 | 64 | 2 | PF04856 | |
| Domain | Securin_separation_inhibitor | 1.16e-05 | 2 | 64 | 2 | IPR006940 | |
| Domain | Iontro_rcpt | 3.02e-05 | 18 | 64 | 3 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 3.02e-05 | 18 | 64 | 3 | PF10613 | |
| Domain | Iono_rcpt_met | 3.02e-05 | 18 | 64 | 3 | IPR001508 | |
| Domain | Glu/Gly-bd | 3.02e-05 | 18 | 64 | 3 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 3.02e-05 | 18 | 64 | 3 | SM00918 | |
| Domain | Lig_chan | 3.02e-05 | 18 | 64 | 3 | PF00060 | |
| Domain | PBPe | 3.02e-05 | 18 | 64 | 3 | SM00079 | |
| Domain | PDZ | 1.22e-04 | 141 | 64 | 5 | PF00595 | |
| Domain | PDZ | 1.53e-04 | 148 | 64 | 5 | SM00228 | |
| Domain | - | 1.63e-04 | 150 | 64 | 5 | 2.30.42.10 | |
| Domain | PDZ | 1.68e-04 | 151 | 64 | 5 | PS50106 | |
| Domain | PDZ | 1.73e-04 | 152 | 64 | 5 | IPR001478 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.02e-03 | 14 | 64 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.02e-03 | 14 | 64 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.02e-03 | 14 | 64 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.02e-03 | 14 | 64 | 2 | PF08393 | |
| Domain | MT | 1.02e-03 | 14 | 64 | 2 | PF12777 | |
| Domain | AAA_8 | 1.02e-03 | 14 | 64 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 1.02e-03 | 14 | 64 | 2 | IPR011704 | |
| Domain | AAA_5 | 1.02e-03 | 14 | 64 | 2 | PF07728 | |
| Domain | DHC_fam | 1.18e-03 | 15 | 64 | 2 | IPR026983 | |
| Domain | PLipase_C_Pinositol-sp_Y | 1.18e-03 | 15 | 64 | 2 | IPR001711 | |
| Domain | EF-hand_like | 1.18e-03 | 15 | 64 | 2 | PF09279 | |
| Domain | PIPLC_Y_DOMAIN | 1.18e-03 | 15 | 64 | 2 | PS50008 | |
| Domain | Dynein_heavy_dom | 1.18e-03 | 15 | 64 | 2 | IPR004273 | |
| Domain | PI-PLC_fam | 1.18e-03 | 15 | 64 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 1.18e-03 | 15 | 64 | 2 | IPR015359 | |
| Domain | PI-PLC-Y | 1.18e-03 | 15 | 64 | 2 | PF00387 | |
| Domain | PLCYc | 1.18e-03 | 15 | 64 | 2 | SM00149 | |
| Domain | Dynein_heavy | 1.18e-03 | 15 | 64 | 2 | PF03028 | |
| Domain | PI-PLC-X | 1.71e-03 | 18 | 64 | 2 | PF00388 | |
| Domain | PLCXc | 1.71e-03 | 18 | 64 | 2 | SM00148 | |
| Domain | PIPLC_X_DOMAIN | 1.90e-03 | 19 | 64 | 2 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 1.90e-03 | 19 | 64 | 2 | IPR000909 | |
| Domain | - | 3.30e-03 | 25 | 64 | 2 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 3.30e-03 | 25 | 64 | 2 | IPR017946 | |
| Domain | P-loop_NTPase | 8.16e-03 | 848 | 64 | 8 | IPR027417 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 3.04e-06 | 30 | 48 | 4 | M18193 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 3.97e-06 | 32 | 48 | 4 | MM15143 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 4.37e-06 | 10 | 48 | 3 | M10272 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 7.50e-06 | 140 | 48 | 6 | M42572 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 7.98e-06 | 12 | 48 | 3 | MM15142 | |
| Pathway | BIOCARTA_CK1_PATHWAY | 1.64e-05 | 15 | 48 | 3 | MM1468 | |
| Pathway | BIOCARTA_CK1_PATHWAY | 2.01e-05 | 16 | 48 | 3 | M16626 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 4.85e-04 | 193 | 48 | 5 | MM14890 | |
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 11682618 | ||
| Pubmed | PTTG is a secretory protein in human pituitary adenomas and in mouse pituitary tumor cell lines. | 7.15e-09 | 3 | 68 | 3 | 17652795 | |
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 33173537 | ||
| Pubmed | PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression. | 7.15e-09 | 3 | 68 | 3 | 37159932 | |
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 24395789 | ||
| Pubmed | The lifespan quantitative trait locus gene Securin controls hematopoietic progenitor cell function. | 7.15e-09 | 3 | 68 | 3 | 31073078 | |
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 34262048 | ||
| Pubmed | Pituitary tumor transforming gene as a novel regulatory factor of liver fibrosis. | 7.15e-09 | 3 | 68 | 3 | 25936962 | |
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 16322543 | ||
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 36737842 | ||
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 17626243 | ||
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 15281346 | ||
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 20153804 | ||
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 18639540 | ||
| Pubmed | Kainate receptor-mediated responses in the CA1 field of wild-type and GluR6-deficient mice. | 7.15e-09 | 3 | 68 | 3 | 9880586 | |
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 31513786 | ||
| Pubmed | Pituitary tumor transforming gene (PTTG) transforming and transactivation activity. | 7.15e-09 | 3 | 68 | 3 | 10713046 | |
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 12626748 | ||
| Pubmed | Differential trafficking of GluR7 kainate receptor subunit splice variants. | 7.15e-09 | 3 | 68 | 3 | 15805114 | |
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 28516917 | ||
| Pubmed | Sex-steroid milieu determines diabetes rescue in pttg-null mice. | 7.15e-09 | 3 | 68 | 3 | 16731783 | |
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 16959877 | ||
| Pubmed | Characterization of the murine pituitary tumor transforming gene (PTTG) and its promoter. | 7.15e-09 | 3 | 68 | 3 | 10650958 | |
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 23867215 | ||
| Pubmed | Characterization of the pituitary tumor transforming gene 1 knockout mouse retina. | 7.15e-09 | 3 | 68 | 3 | 21203837 | |
| Pubmed | Murine pituitary tumor-transforming gene functions as a securin protein in insulin-secreting cells. | 7.15e-09 | 3 | 68 | 3 | 17065388 | |
| Pubmed | Pituitary hypoplasia in Pttg-/- mice is protective for Rb+/- pituitary tumorigenesis. | 2.86e-08 | 4 | 68 | 3 | 15919720 | |
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 22342753 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 16030258 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 16720305 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 17127711 | ||
| Pubmed | Tumor suppressor activity of KLF6 mediated by downregulation of the PTTG1 oncogene. | 2.86e-08 | 4 | 68 | 3 | 20116377 | |
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 23677169 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 19124608 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 19477929 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 35050550 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 11516952 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 15513934 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 23164239 | ||
| Pubmed | Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice. | 2.86e-08 | 4 | 68 | 3 | 23861251 | |
| Pubmed | Spatial learning and long-term memory impairments in RasGrf1 KO, Pttg1 KO, and double KO mice. | 2.86e-08 | 4 | 68 | 3 | 30259712 | |
| Pubmed | Reduced synaptic function of Kainate receptors in the insular cortex of Fmr1 Knock-out mice. | 2.86e-08 | 4 | 68 | 3 | 30241548 | |
| Pubmed | Expression of PTTG and prc1 genes during telencephalic neurogenesis. | 2.86e-08 | 4 | 68 | 3 | 10727870 | |
| Pubmed | Pituitary tumor-transforming gene 1 regulates the patterning of retinal mosaics. | 2.86e-08 | 4 | 68 | 3 | 24927528 | |
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 16533944 | ||
| Pubmed | Separase: a universal trigger for sister chromatid disjunction but not chromosome cycle progression. | 2.86e-08 | 4 | 68 | 3 | 16533945 | |
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 17039256 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 25421944 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 19369569 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 17234588 | ||
| Pubmed | Homologue disjunction in mouse oocytes requires proteolysis of securin and cyclin B1. | 2.86e-08 | 4 | 68 | 3 | 14593421 | |
| Pubmed | Securin regulates entry into M-phase by modulating the stability of cyclin B. | 2.86e-08 | 4 | 68 | 3 | 18364698 | |
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 18417614 | ||
| Pubmed | Developmental expression patterns of kainate receptors in the mouse spinal cord. | 7.13e-08 | 5 | 68 | 3 | 23076118 | |
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 18981426 | ||
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 28228252 | ||
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 39093409 | ||
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 21156286 | ||
| Pubmed | PTTG-binding factor (PBF) is a novel regulator of the thyroid hormone transporter MCT8. | 7.13e-08 | 5 | 68 | 3 | 22535767 | |
| Pubmed | Development of laminar distributions of kainate receptors in the somatosensory cortex of mice. | 7.13e-08 | 5 | 68 | 3 | 9593973 | |
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 28658604 | ||
| Pubmed | Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth. | 7.13e-08 | 5 | 68 | 3 | 17975001 | |
| Pubmed | Kainate receptors: pharmacology, function and therapeutic potential. | 7.13e-08 | 5 | 68 | 3 | 18793656 | |
| Pubmed | The meiosis I-to-meiosis II transition in mouse oocytes requires separase activity. | 7.13e-08 | 5 | 68 | 3 | 14561405 | |
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 12223554 | ||
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 18358623 | ||
| Pubmed | Preferential assembly of heteromeric kainate and AMPA receptor amino terminal domains. | 7.13e-08 | 5 | 68 | 3 | 29058671 | |
| Pubmed | The Rae1-Nup98 complex prevents aneuploidy by inhibiting securin degradation. | 7.13e-08 | 5 | 68 | 3 | 16355229 | |
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 21076990 | ||
| Pubmed | 1.42e-07 | 6 | 68 | 3 | 33181265 | ||
| Pubmed | N-glycan content modulates kainate receptor functional properties. | 1.42e-07 | 6 | 68 | 3 | 28714086 | |
| Pubmed | mTOR promotes pituitary tumor development through activation of PTTG1. | 1.42e-07 | 6 | 68 | 3 | 27524416 | |
| Pubmed | 1.42e-07 | 6 | 68 | 3 | 21991377 | ||
| Pubmed | 2.49e-07 | 7 | 68 | 3 | 17428973 | ||
| Pubmed | Loss of Cdc20 causes a securin-dependent metaphase arrest in two-cell mouse embryos. | 2.49e-07 | 7 | 68 | 3 | 17325031 | |
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 2.49e-07 | 7 | 68 | 3 | 9016303 | |
| Pubmed | 2.49e-07 | 7 | 68 | 3 | 19342380 | ||
| Pubmed | Glutamate receptors: brain function and signal transduction. | 2.49e-07 | 7 | 68 | 3 | 9651535 | |
| Pubmed | 2.49e-07 | 7 | 68 | 3 | 1310861 | ||
| Pubmed | Transmembrane topology of the glutamate receptor subunit GluR6. | 3.98e-07 | 8 | 68 | 3 | 8163463 | |
| Pubmed | Identification of disease-relevant modulators of the SHH pathway in the developing brain. | 5.95e-07 | 9 | 68 | 3 | 34463328 | |
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 5.95e-07 | 9 | 68 | 3 | 9051806 | |
| Pubmed | Nuclear pore protein NUP88 activates anaphase-promoting complex to promote aneuploidy. | 8.49e-07 | 10 | 68 | 3 | 26731471 | |
| Pubmed | 1.17e-06 | 11 | 68 | 3 | 21494564 | ||
| Pubmed | Specificity and Redundancy of Profilin 1 and 2 Function in Brain Development and Neuronal Structure. | 2.02e-06 | 13 | 68 | 3 | 34571959 | |
| Pubmed | 2.02e-06 | 13 | 68 | 3 | 19213844 | ||
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 2.02e-06 | 13 | 68 | 3 | 20859245 | |
| Pubmed | 2.05e-06 | 300 | 68 | 7 | 19086053 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | PDS5B PTTG3P PTTG1 GTF2I NUP85 RRP12 MOB1A PRKAR2A KIF14 PLK4 PTTG2 BAP1 | 2.23e-06 | 1155 | 68 | 12 | 20360068 |
| Pubmed | PRRC2C DIAPH2 PLCB1 PRKAR2A SYNPO GRIK2 GRIK3 PLCL1 ARHGAP21 FOXG1 CNP | 2.51e-06 | 963 | 68 | 11 | 28671696 | |
| Pubmed | 3.20e-06 | 15 | 68 | 3 | 21163256 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 12947409 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 15673679 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 19320626 | ||
| Pubmed | D1 dopamine receptor coupling to PLCβ regulates forward locomotion in mice. | 3.77e-06 | 2 | 68 | 2 | 24227722 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 33173433 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 11182092 | ||
| Pubmed | Kainate receptor-mediated synaptic transmission in the adult anterior cingulate cortex. | 3.77e-06 | 2 | 68 | 2 | 15928066 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 14724198 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17620617 | ||
| Interaction | PRPS2 interactions | 1.69e-06 | 253 | 66 | 8 | int:PRPS2 | |
| Interaction | GRIK4 interactions | 1.86e-06 | 8 | 66 | 3 | int:GRIK4 | |
| Interaction | GRIK2 interactions | 3.52e-06 | 32 | 66 | 4 | int:GRIK2 | |
| Interaction | GRIK3 interactions | 3.96e-06 | 10 | 66 | 3 | int:GRIK3 | |
| Interaction | CCDC15 interactions | 7.23e-06 | 12 | 66 | 3 | int:CCDC15 | |
| Interaction | FLNA interactions | USP14 SYNPO2 DRD1 LAD1 KIF14 GRIK1 SYNPO GRIK3 TRIM44 ARHGAP21 BAP1 | 7.51e-06 | 648 | 66 | 11 | int:FLNA |
| Interaction | PCNT interactions | 1.37e-05 | 241 | 66 | 7 | int:PCNT | |
| Interaction | GRIK5 interactions | 3.68e-05 | 20 | 66 | 3 | int:GRIK5 | |
| Interaction | SMC3 interactions | 5.42e-05 | 408 | 66 | 8 | int:SMC3 | |
| Interaction | HAPSTR1 interactions | PDS5B GTF2I NUP85 ATRX PRRC2C RRP12 PLCB1 SHMT1 KIF14 SYNPO BAP1 | 7.24e-05 | 829 | 66 | 11 | int:HAPSTR1 |
| Interaction | WDR1 interactions | 8.32e-05 | 220 | 66 | 6 | int:WDR1 | |
| Interaction | RHOA interactions | SYNPO2 NUP85 TIAM1 SRGAP1 RRP12 DIAPH2 KIF14 SRPRA RPGR LRRC8D ARHGAP21 CNP BAP1 | 1.17e-04 | 1199 | 66 | 13 | int:RHOA |
| Cytoband | 5q35.1 | 2.53e-05 | 38 | 68 | 3 | 5q35.1 | |
| Cytoband | 11p13 | 3.16e-03 | 56 | 68 | 2 | 11p13 | |
| Cytoband | 21q22.11 | 3.86e-03 | 62 | 68 | 2 | 21q22.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p13 | 4.23e-03 | 65 | 68 | 2 | chr11p13 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 1.34e-07 | 5 | 44 | 3 | 1199 | |
| GeneFamily | PDZ domain containing | 3.28e-05 | 152 | 44 | 5 | 1220 | |
| GeneFamily | Dyneins, axonemal | 7.69e-04 | 17 | 44 | 2 | 536 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 9.64e-04 | 19 | 44 | 2 | 832 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 6.58e-03 | 50 | 44 | 2 | 721 | |
| Coexpression | GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 1.24e-05 | 197 | 68 | 6 | M5347 | |
| Coexpression | LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL | 1.57e-05 | 19 | 68 | 3 | MM848 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | 2.31e-05 | 597 | 68 | 9 | MM1309 | |
| Coexpression | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 | 2.41e-05 | 458 | 68 | 8 | M8520 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | 3.27e-05 | 478 | 68 | 8 | M45785 | |
| Coexpression | VIETOR_IFRD1_TARGETS | 4.67e-05 | 27 | 68 | 3 | MM655 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_DN | 7.84e-05 | 87 | 68 | 4 | MM992 | |
| Coexpression | CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN | 8.62e-05 | 33 | 68 | 3 | M1252 | |
| Coexpression | LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN | 1.03e-04 | 35 | 68 | 3 | MM542 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | PDS5B PTTG3P PTTG1 BRIP1 NUP85 ANKRD13C ABHD3 SHMT1 KIF14 GRIK2 FSBP PLK4 | 1.08e-04 | 1290 | 68 | 12 | M80 |
| Coexpression | CROONQUIST_IL6_DEPRIVATION_DN | 1.10e-04 | 95 | 68 | 4 | M18506 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | 1.13e-04 | 571 | 68 | 8 | MM1100 | |
| Coexpression | GSE3982_NKCELL_VS_TH1_UP | 1.54e-04 | 195 | 68 | 5 | M5593 | |
| Coexpression | GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN | 1.70e-04 | 199 | 68 | 5 | M8979 | |
| Coexpression | GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 1.70e-04 | 199 | 68 | 5 | M9697 | |
| Coexpression | GSE7460_CD8_TCELL_VS_TREG_ACT_DN | 1.70e-04 | 199 | 68 | 5 | M5684 | |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP | 1.74e-04 | 200 | 68 | 5 | M8090 | |
| Coexpression | GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_DN | 1.74e-04 | 200 | 68 | 5 | M2930 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 1.74e-04 | 200 | 68 | 5 | M5901 | |
| Coexpression | GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN | 1.74e-04 | 200 | 68 | 5 | M6095 | |
| Coexpression | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C | 1.74e-04 | 454 | 68 | 7 | M19927 | |
| Coexpression | CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE | 1.78e-04 | 42 | 68 | 3 | MM617 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_4HR | 1.91e-04 | 43 | 68 | 3 | MM1204 | |
| Coexpression | MANALO_HYPOXIA_UP | 1.95e-04 | 205 | 68 | 5 | M259 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 1.99e-04 | 206 | 68 | 5 | M39254 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | USP14 PTTG3P PTTG1 SYNPO2 BRIP1 NUP85 PRRC2C VCAN CCDC18 KIF14 PLK4 CD200 | 2.43e-04 | 1407 | 68 | 12 | M14427 |
| Coexpression | LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP | 2.50e-04 | 47 | 68 | 3 | MM539 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_DN | 2.58e-04 | 341 | 68 | 6 | M2879 | |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_24HR | 2.66e-04 | 48 | 68 | 3 | MM1181 | |
| Coexpression | YAGI_AML_WITH_11Q23_REARRANGED | 2.79e-04 | 346 | 68 | 6 | M17123 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.45e-05 | 256 | 66 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | PDS5B KLHL24 SYNPO2 GTF2I ATRX NALCN PRRC2C VCAN MOB1A PLCB1 TRIM44 | 4.02e-05 | 818 | 66 | 11 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.38e-08 | 200 | 68 | 7 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | PBMC-Control-cDC_10|Control / Compartment, Disease Groups and Clusters | 3.95e-07 | 185 | 68 | 6 | 4b5a7450fed912f340da16065c1e65d626dbe8d1 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_mature_DC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.06e-07 | 193 | 68 | 6 | d9be4d1de863fffc2240d6fd1a2f8dfb2d2bc916 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.05e-07 | 199 | 68 | 6 | 88d130e2451e61afb710edf552e6b346b9fcfb2b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-06 | 165 | 68 | 5 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 5.89e-06 | 168 | 68 | 5 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 5.89e-06 | 168 | 68 | 5 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 6.07e-06 | 169 | 68 | 5 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | (7)_MNP-(7)_DC_activated|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.24e-06 | 170 | 68 | 5 | 4ab495b38a071fa8207331df2ce0d78a2dcd034e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.42e-06 | 171 | 68 | 5 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.42e-06 | 171 | 68 | 5 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.80e-06 | 173 | 68 | 5 | 7a3115e7cf7e2f345192cde0656a7f0193594a5f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.99e-06 | 174 | 68 | 5 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.69e-06 | 182 | 68 | 5 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.17e-06 | 184 | 68 | 5 | 1edefa2a049d7e22d0bdb1ea3d7ef1c8d6ae0fe3 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.17e-06 | 184 | 68 | 5 | 8578c50eaa8ce1cefc0228185c66c8e25f4bfc32 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 9.17e-06 | 184 | 68 | 5 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | (7)_DC_activated|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 9.17e-06 | 184 | 68 | 5 | b89871a3e36fde6daa68daf116f8c8d587554c0f | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 9.41e-06 | 185 | 68 | 5 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.66e-06 | 186 | 68 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.91e-06 | 187 | 68 | 5 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.91e-06 | 187 | 68 | 5 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.02e-05 | 188 | 68 | 5 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 194 | 68 | 5 | 1a2090e997c70433d07f56bf7cb0a50c4151118c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 194 | 68 | 5 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | control-Lymphocytic-Prol._cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.18e-05 | 194 | 68 | 5 | 4c76508de3291c952386caffda2d559629ba5998 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.21e-05 | 195 | 68 | 5 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 195 | 68 | 5 | 75759fd7f925725f0ecd07214afcca5aa2158f9e | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.21e-05 | 195 | 68 | 5 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 1.24e-05 | 196 | 68 | 5 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 1.24e-05 | 196 | 68 | 5 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.24e-05 | 196 | 68 | 5 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | control-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.24e-05 | 196 | 68 | 5 | 886f7c865b086d6ebb4a1746865c30af6bbed345 | |
| ToppCell | Healthy-T/NK_proliferative|World / disease group, cell group and cell class | 1.27e-05 | 197 | 68 | 5 | e90be1e7e02f736b6aab14010a912b592d6f1e80 | |
| ToppCell | BAL-Mild-cDC_10|Mild / Compartment, Disease Groups and Clusters | 1.27e-05 | 197 | 68 | 5 | c0550d41dd5619b369b590f3d6a61154dd7b2cab | |
| ToppCell | T_cells-Treg_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.27e-05 | 197 | 68 | 5 | de5448fcdf4e433fc167496413abe5d0c8a5c6d8 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 197 | 68 | 5 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | 1.27e-05 | 197 | 68 | 5 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 | |
| ToppCell | (5)_Dendritic_cell-(53)_Lymphoid_DC|(5)_Dendritic_cell / shred on Cell_type and subtype | 1.31e-05 | 198 | 68 | 5 | 548da5fa86f9756c503ed77bcdde55bc4d1a2726 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.31e-05 | 198 | 68 | 5 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.31e-05 | 198 | 68 | 5 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | T_cells-GZMK+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.31e-05 | 198 | 68 | 5 | 085ba270f9defbf5ef45108c6d870e1d7c428479 | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 1.34e-05 | 199 | 68 | 5 | 5c8b847b794b3e88722f5b841f2539a27251106c | |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 1.34e-05 | 199 | 68 | 5 | d44cc74d7171d96add61dae821daf774b17d4c69 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 1.34e-05 | 199 | 68 | 5 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.34e-05 | 199 | 68 | 5 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | BAL-Severe-cDC_10|Severe / Compartment, Disease Groups and Clusters | 1.34e-05 | 199 | 68 | 5 | 54bdadd04abaf8caa948b0177c037bc089ca07e6 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|bone_marrow / Manually curated celltypes from each tissue | 1.34e-05 | 199 | 68 | 5 | 961666a677589c65f733f7262822689101d39ae3 | |
| ToppCell | Healthy_donor-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 1.34e-05 | 199 | 68 | 5 | 1311dfd74b991f48b047a439f04f9bf7dfaa0e7a | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / disease group, cell group and cell class | 1.34e-05 | 199 | 68 | 5 | af78837f3a7641a5bd98765eef9cb4f86034048c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.34e-05 | 199 | 68 | 5 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.34e-05 | 199 | 68 | 5 | df2fcaf01b1b48632f84e7355ef21d20853f0664 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.37e-05 | 200 | 68 | 5 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.37e-05 | 200 | 68 | 5 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.37e-05 | 200 | 68 | 5 | 6a44439e4a7ce3627271375b04cfcfb9467218f4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.37e-05 | 200 | 68 | 5 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_Macrophages|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.37e-05 | 200 | 68 | 5 | ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.37e-05 | 200 | 68 | 5 | 1a04331862079092bc04b1010aa9228c0fa3d8c5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.37e-05 | 200 | 68 | 5 | 8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.37e-05 | 200 | 68 | 5 | 05bcde6ce8f1354ef65e4eb9cbd963a92108081c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.37e-05 | 200 | 68 | 5 | cb1f4b0d66da5b0466ff17b29e7034d451d93e4f | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.37e-05 | 200 | 68 | 5 | fb56d430957e73fba17db7bc0127ecf3577e0867 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.68e-05 | 100 | 68 | 4 | 3a7e5469de88745ac455c35deeb859d68dce73fa | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.68e-05 | 100 | 68 | 4 | 187e31d4186b82a37569b98d83e4813017cc2ddd | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-7|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.60e-05 | 136 | 68 | 4 | d94f0fbeb7b80d4cf0687d1924ebf8f9dd07358c | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT|GI_small-bowel / Manually curated celltypes from each tissue | 7.57e-05 | 147 | 68 | 4 | 4ba9a86ab7033688a9a2a2dc84c001a49af835b4 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_Inf._Macrophages|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.40e-05 | 151 | 68 | 4 | 88f7498f29e43441e0982f9f97ea563edf2835a4 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.62e-05 | 152 | 68 | 4 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | Influenza_Severe-CD4+_CTL|World / Disease group and Cell class | 8.84e-05 | 153 | 68 | 4 | 0c6c2c6dbc81badd886f125f4e5ba0fb7d52101c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.30e-05 | 155 | 68 | 4 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-6|TCGA-Kidney / Sample_Type by Project: Shred V9 | 9.53e-05 | 156 | 68 | 4 | d249747c7108a0edfc72d24c09b0b0e4ed662b40 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.77e-05 | 157 | 68 | 4 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.08e-04 | 161 | 68 | 4 | 048b7dc00746987a24bf870d4d278c4183eb04a2 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.13e-04 | 163 | 68 | 4 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.16e-04 | 164 | 68 | 4 | 08819970174a3eb4eee8e1e675075828665b845e | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 164 | 68 | 4 | 67c636a2cc32e56c6186dc7e779cc19af04639d2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 165 | 68 | 4 | e2aebb2fe197151e019371b8960f76f0c2386f08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 165 | 68 | 4 | b087771499aeb31cc4a338d2d0a9392a4ec1ac45 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-04 | 165 | 68 | 4 | 9d2bdc42c13c8c2a68889bec8612a1ce56f659fa | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 165 | 68 | 4 | d8f8b088fd28a6b9dbd6b51bcaee42000e963321 | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 1.18e-04 | 165 | 68 | 4 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.21e-04 | 166 | 68 | 4 | a7ac5a414e3e2ff01f1c452c0a85048b17cba0b6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 167 | 68 | 4 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | 10x5'-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue | 1.24e-04 | 167 | 68 | 4 | 82739226347d74897be000f429b73543a031af96 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-04 | 167 | 68 | 4 | 3461d14e36f09ddc6ee5549ca4797e16d3f37fcc | |
| ToppCell | 10x5'-Lung-Hematopoietic_progenitors|Lung / Manually curated celltypes from each tissue | 1.24e-04 | 167 | 68 | 4 | dec18caf0475002d4ad3c7bc7fc3050cbc8e6bae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 167 | 68 | 4 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-04 | 168 | 68 | 4 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.27e-04 | 168 | 68 | 4 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 169 | 68 | 4 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.30e-04 | 169 | 68 | 4 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-04 | 169 | 68 | 4 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-04 | 169 | 68 | 4 | 44d201361eb497222a4972a0e10bac1e05dcfd0a | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-04 | 170 | 68 | 4 | 513d9036aa41d4d902da8baa66a66206abb6f3b0 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_mature_DC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.36e-04 | 171 | 68 | 4 | 341f9f79c1ed654ab347e25dc4936f89ffdf9617 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 171 | 68 | 4 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 172 | 68 | 4 | 073a503dc922e3e3ac3528e249b0f8b74402110b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 172 | 68 | 4 | 35c20de4db47dbf31c857d23c7a25cd7f95c085c | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.42e-04 | 173 | 68 | 4 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 174 | 68 | 4 | 84da9faff088d05233183b425385beb054c92d1b | |
| Drug | Crotamiton [483-63-6]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 9.65e-07 | 179 | 67 | 7 | 3388_DN | |
| Drug | 0316684-0000 [391209-55-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.60e-06 | 193 | 67 | 7 | 7052_DN | |
| Drug | Niflumic acid [4394-00-7]; Up 200; 14.2uM; PC3; HT_HG-U133A | 1.96e-06 | 199 | 67 | 7 | 5071_UP | |
| Drug | LY339434 | 2.02e-06 | 9 | 67 | 3 | CID006324635 | |
| Drug | milrinone | 5.30e-06 | 150 | 67 | 6 | CID000004197 | |
| Drug | caffeine | 5.43e-06 | 562 | 67 | 10 | CID000002519 | |
| Drug | spegazzinine | 8.53e-06 | 2 | 67 | 2 | CID003083986 | |
| Drug | 5-nitro-6,7,8,9-tetrahydrobenzo(G)indole-2,3-dione-3-oxime | 8.53e-06 | 2 | 67 | 2 | ctd:C084273 | |
| Drug | decahydroisoquinoline | 1.33e-05 | 16 | 67 | 3 | CID000097812 | |
| Drug | genistein; Up 200; 10uM; HL60; HT_HG-U133A | 1.46e-05 | 179 | 67 | 6 | 1176_UP | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; PC3; HT_HG-U133A | 1.70e-05 | 184 | 67 | 6 | 7295_UP | |
| Drug | EN-1530 | 1.75e-05 | 278 | 67 | 7 | CID000004425 | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | 1.92e-05 | 188 | 67 | 6 | 4545_DN | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.92e-05 | 188 | 67 | 6 | 4845_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; HL60; HT_HG-U133A | 2.10e-05 | 191 | 67 | 6 | 6173_DN | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.16e-05 | 192 | 67 | 6 | 6223_DN | |
| Drug | LY382884 | 2.28e-05 | 19 | 67 | 3 | CID000656723 | |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.30e-05 | 194 | 67 | 6 | 3867_DN | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.36e-05 | 195 | 67 | 6 | 5299_UP | |
| Drug | (+/-)-blebbistatin; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 2.43e-05 | 196 | 67 | 6 | 837_UP | |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.43e-05 | 196 | 67 | 6 | 7357_DN | |
| Drug | Naproxen [22204-53-1]; Down 200; 17.4uM; PC3; HT_HG-U133A | 2.50e-05 | 197 | 67 | 6 | 1828_DN | |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; PC3; HT_HG-U133A | 2.50e-05 | 197 | 67 | 6 | 4216_DN | |
| Drug | (cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; MCF7; HT_HG-U133A | 2.50e-05 | 197 | 67 | 6 | 3889_DN | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.57e-05 | 198 | 67 | 6 | 5500_UP | |
| Drug | Altretamine [654-05-6]; Up 200; 19uM; MCF7; HT_HG-U133A | 2.65e-05 | 199 | 67 | 6 | 5688_UP | |
| Drug | 5162773; Up 200; 7uM; MCF7; HT_HG-U133A_EA | 2.65e-05 | 199 | 67 | 6 | 892_UP | |
| Drug | NS 102 | 3.60e-05 | 22 | 67 | 3 | CID005282252 | |
| Drug | aminothiazole 6 | 5.10e-05 | 4 | 67 | 2 | CID005329388 | |
| Drug | acromelic acid B | 5.10e-05 | 4 | 67 | 2 | CID000158974 | |
| Drug | Brn 1074551 | 5.10e-05 | 4 | 67 | 2 | CID000120220 | |
| Drug | potassium tetrathionate | 5.10e-05 | 4 | 67 | 2 | CID000061701 | |
| Drug | diCl-HQC | 5.10e-05 | 4 | 67 | 2 | CID003018579 | |
| Drug | felbamate | 5.43e-05 | 70 | 67 | 4 | CID000003331 | |
| Drug | guanine | GABRP USP14 PTTG1 NPR3 DRD1 BRIP1 TIAM1 PLCB1 SHMT1 PRKAR2A GRIK1 | 5.99e-05 | 902 | 67 | 11 | CID000000764 |
| Drug | zaprinast | 6.02e-05 | 141 | 67 | 5 | CID000005722 | |
| Drug | AC1L1DME | 7.11e-05 | 75 | 67 | 4 | CID000002414 | |
| Drug | ipenoxazone | 8.48e-05 | 5 | 67 | 2 | CID000065882 | |
| Drug | pBB-PzDA | 8.48e-05 | 5 | 67 | 2 | CID000124528 | |
| Drug | tibalosine | 8.48e-05 | 5 | 67 | 2 | CID000068828 | |
| Drug | bromowillardiine | 8.48e-05 | 5 | 67 | 2 | CID000167842 | |
| Drug | 3-hydroxy-2-quinoxalinecarboxylic acid | 8.48e-05 | 5 | 67 | 2 | CID000071001 | |
| Drug | LY293558 | 9.34e-05 | 30 | 67 | 3 | CID000127894 | |
| Drug | rolipram | 1.00e-04 | 253 | 67 | 6 | CID000005092 | |
| Drug | 4-methylglutamic acid | 1.03e-04 | 31 | 67 | 3 | CID000005365 | |
| Drug | D-N-Q | 1.11e-04 | 84 | 67 | 4 | CID000003140 | |
| Drug | willardine | 1.14e-04 | 32 | 67 | 3 | CID000005123 | |
| Drug | ketamine | 1.22e-04 | 262 | 67 | 6 | CID000003821 | |
| Drug | 3-acetylisoquinoline | 1.27e-04 | 6 | 67 | 2 | CID000124656 | |
| Drug | propylbutyldopamine | 1.27e-04 | 6 | 67 | 2 | CID000156067 | |
| Drug | ethylamine hydrochloride | 1.27e-04 | 6 | 67 | 2 | CID000011198 | |
| Drug | haloperidol | 1.57e-04 | 394 | 67 | 7 | CID000003559 | |
| Drug | papaverine | 1.71e-04 | 176 | 67 | 5 | CID000004680 | |
| Drug | fluorocyclobutane | 1.77e-04 | 7 | 67 | 2 | CID011051569 | |
| Drug | H-8105 | 1.81e-04 | 282 | 67 | 6 | CID000164531 | |
| Drug | L-quisqualic acid | 1.90e-04 | 180 | 67 | 5 | CID000001209 | |
| Drug | L-BMAA | 1.91e-04 | 38 | 67 | 3 | CID000028558 | |
| Drug | 7-OH-DPAT | 2.06e-04 | 39 | 67 | 3 | CID000001219 | |
| Drug | DETC-MeSO | 2.06e-04 | 39 | 67 | 3 | CID003035711 | |
| Drug | Ethylnitrosourea | 2.15e-04 | 291 | 67 | 6 | ctd:D005038 | |
| Drug | Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.27e-04 | 187 | 67 | 5 | 1242_UP | |
| Drug | 2-bromoethylamine | 2.36e-04 | 8 | 67 | 2 | ctd:C004504 | |
| Drug | AC1L1B65 | 2.36e-04 | 8 | 67 | 2 | CID000001300 | |
| Drug | perzinfotel | 2.36e-04 | 8 | 67 | 2 | CID006918236 | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.38e-04 | 189 | 67 | 5 | 6793_DN | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 2.38e-04 | 189 | 67 | 5 | 1700_UP | |
| Drug | cyclothiazide | 2.43e-04 | 103 | 67 | 4 | CID000002910 | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 2.44e-04 | 190 | 67 | 5 | 4507_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.44e-04 | 190 | 67 | 5 | 2137_DN | |
| Drug | Latex | 2.50e-04 | 191 | 67 | 5 | ctd:D007840 | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.56e-04 | 192 | 67 | 5 | 5216_UP | |
| Drug | tetradotoxin | 2.60e-04 | 428 | 67 | 7 | CID000020382 | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; MCF7; HT_HG-U133A | 2.62e-04 | 193 | 67 | 5 | 3209_DN | |
| Drug | Clobetasol propionate [25122-46-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.62e-04 | 193 | 67 | 5 | 6835_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.62e-04 | 193 | 67 | 5 | 3841_DN | |
| Drug | Rp-cAMPS | 2.68e-04 | 194 | 67 | 5 | CID006426631 | |
| Drug | H-7 dihydrochloride; Up 200; 100uM; MCF7; HT_HG-U133A | 2.68e-04 | 194 | 67 | 5 | 5936_UP | |
| Drug | Domperidone maleate; Down 200; 7.4uM; MCF7; HT_HG-U133A | 2.68e-04 | 194 | 67 | 5 | 2655_DN | |
| Drug | SB 202190; Down 200; 1uM; PC3; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 7058_DN | |
| Drug | N6-methyladenosine [1867-73-8]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 2626_UP | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 6654_DN | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; HL60; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 1184_UP | |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; MCF7; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 3459_DN | |
| Drug | Cisapride [81098-60-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 5305_UP | |
| Drug | Metrizamide [31112-62-6]; Up 200; 5uM; HL60; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 1318_UP | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 4063_UP | |
| Drug | ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 2.75e-04 | 195 | 67 | 5 | 866_UP | |
| Drug | Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; PC3; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 6661_DN | |
| Drug | Joro spider toxin | 2.76e-04 | 43 | 67 | 3 | CID000119582 | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 5425_DN | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 7226_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 6954_DN | |
| Drug | Dequalinium dichloride [522-51-0]; Up 200; 7.6uM; HL60; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 1276_UP | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 1687_UP | |
| Drug | Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 2301_UP | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 6924_DN | |
| Drug | Cyclosporin A [59865-13-3]; Down 200; 3.4uM; PC3; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 4586_DN | |
| Drug | AG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 6435_UP | |
| Drug | Metformin hydrochloride [1115-70-4]; Up 200; 24.2uM; HL60; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 1858_UP | |
| Drug | staurosporine; Up 200; 0.01uM; SKMEL5; HG-U133A | 2.88e-04 | 197 | 67 | 5 | 508_UP | |
| Disease | cortisol secretion measurement | 9.96e-05 | 7 | 65 | 2 | EFO_0004642 | |
| Disease | chronic fatigue syndrome (is_marker_for) | 2.13e-04 | 10 | 65 | 2 | DOID:8544 (is_marker_for) | |
| Disease | Neuroendocrine Tumors | 2.59e-04 | 11 | 65 | 2 | C0206754 | |
| Disease | Unipolar Depression | 2.69e-04 | 259 | 65 | 5 | C0041696 | |
| Disease | Sjogren's Syndrome | 3.67e-04 | 13 | 65 | 2 | C1527336 | |
| Disease | Sicca Syndrome | 3.67e-04 | 13 | 65 | 2 | C0086981 | |
| Disease | unipolar depression, bipolar disorder | 3.96e-04 | 156 | 65 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | urate measurement, bone density | 4.20e-04 | 619 | 65 | 7 | EFO_0003923, EFO_0004531 | |
| Disease | Microcephaly | 4.42e-04 | 67 | 65 | 3 | C0025958 | |
| Disease | MYELODYSPLASTIC SYNDROME | 4.42e-04 | 67 | 65 | 3 | C3463824 | |
| Disease | forehead morphology measurement | 4.93e-04 | 15 | 65 | 2 | EFO_0007844 | |
| Disease | serum alanine aminotransferase measurement | 6.27e-04 | 869 | 65 | 8 | EFO_0004735 | |
| Disease | Schizophrenia | 6.96e-04 | 883 | 65 | 8 | C0036341 | |
| Disease | refractive error, age at onset, Myopia | 8.80e-04 | 193 | 65 | 4 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | lung cancer | 9.77e-04 | 21 | 65 | 2 | MONDO_0008903 | |
| Disease | malignant astrocytoma (is_marker_for) | 1.17e-03 | 23 | 65 | 2 | DOID:3069 (is_marker_for) | |
| Disease | Visual seizure | 1.46e-03 | 101 | 65 | 3 | C0270824 | |
| Disease | Epileptic drop attack | 1.46e-03 | 101 | 65 | 3 | C0270846 | |
| Disease | Generalized seizures | 1.46e-03 | 101 | 65 | 3 | C0234533 | |
| Disease | Clonic Seizures | 1.46e-03 | 101 | 65 | 3 | C0234535 | |
| Disease | Vertiginous seizure | 1.46e-03 | 101 | 65 | 3 | C0422855 | |
| Disease | Gustatory seizure | 1.46e-03 | 101 | 65 | 3 | C0422854 | |
| Disease | Seizures, Somatosensory | 1.46e-03 | 101 | 65 | 3 | C0422850 | |
| Disease | Olfactory seizure | 1.46e-03 | 101 | 65 | 3 | C0422853 | |
| Disease | Seizures, Auditory | 1.46e-03 | 101 | 65 | 3 | C0422852 | |
| Disease | Generalized Absence Seizures | 1.46e-03 | 101 | 65 | 3 | C4505436 | |
| Disease | Convulsive Seizures | 1.46e-03 | 101 | 65 | 3 | C0751494 | |
| Disease | Seizures, Sensory | 1.46e-03 | 101 | 65 | 3 | C0751496 | |
| Disease | Jacksonian Seizure | 1.46e-03 | 101 | 65 | 3 | C0022333 | |
| Disease | Non-epileptic convulsion | 1.46e-03 | 101 | 65 | 3 | C0751056 | |
| Disease | Atonic Absence Seizures | 1.46e-03 | 101 | 65 | 3 | C0751123 | |
| Disease | Complex partial seizures | 1.46e-03 | 101 | 65 | 3 | C0149958 | |
| Disease | Single Seizure | 1.46e-03 | 101 | 65 | 3 | C0751110 | |
| Disease | Epileptic Seizures | 1.46e-03 | 101 | 65 | 3 | C4317109 | |
| Disease | Nonepileptic Seizures | 1.46e-03 | 101 | 65 | 3 | C3495874 | |
| Disease | Tonic Seizures | 1.50e-03 | 102 | 65 | 3 | C0270844 | |
| Disease | Absence Seizures | 1.50e-03 | 102 | 65 | 3 | C4316903 | |
| Disease | Convulsions | 1.50e-03 | 102 | 65 | 3 | C4048158 | |
| Disease | Hypermetropia | 1.54e-03 | 103 | 65 | 3 | HP_0000540 | |
| Disease | Seizures, Focal | 1.59e-03 | 104 | 65 | 3 | C0751495 | |
| Disease | Myoclonic Seizures | 1.59e-03 | 104 | 65 | 3 | C4317123 | |
| Disease | Tonic - clonic seizures | 1.59e-03 | 104 | 65 | 3 | C0494475 | |
| Disease | gamma-glutamyltyrosine measurement | 1.62e-03 | 27 | 65 | 2 | EFO_0021144 | |
| Disease | Hematopoetic Myelodysplasia | 1.87e-03 | 29 | 65 | 2 | C2713368 | |
| Disease | Major Depressive Disorder | 2.05e-03 | 243 | 65 | 4 | C1269683 | |
| Disease | Severe Congenital Microcephaly | 2.13e-03 | 31 | 65 | 2 | C3853041 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KSNSFISIPKMEVKS | 376 | Q6UB99 | |
| VEMTKSFDFPTLITK | 741 | P13611 | |
| REKPMLKFSVSFKAN | 376 | Q8N6M5 | |
| RDGSTMTFFKKSKIS | 701 | P39086 | |
| KQTIEFKKMFKSTSD | 216 | B1ANY3 | |
| KKTFKATIAMSQEFP | 446 | Q8N6S4 | |
| MKAKSIREFDKRFTS | 296 | Q8WU67 | |
| TLSRMKDFTKGFSPE | 111 | Q92560 | |
| PESSFKMSFKRETKV | 256 | P21728 | |
| DKFVEKMTSFTKTAR | 941 | O60879 | |
| RTVKPEFEKFSMEVK | 326 | P17342 | |
| PKTDASVKAIFSKVM | 516 | Q9NTI5 | |
| SLMTLSTKTPKDFFT | 181 | Q9UM07 | |
| MADKKYKETFSAPSR | 191 | Q15058 | |
| FRMKPKKENSETTLT | 376 | O00515 | |
| PSFASIIEKMAKSTK | 1521 | Q5CZC0 | |
| DRKEVKMIPKSSFSI | 6 | P55316 | |
| ETSFNKKEKSEMVPS | 36 | Q9BW27 | |
| VKFTKSFELMSPKCS | 436 | Q9HCR9 | |
| FFMKESSTASSREKP | 101 | Q14005 | |
| KKKAVSPENMVTFSE | 66 | P41217 | |
| SSPPRFKTEKMESKT | 1031 | Q9BX63 | |
| FKTEKMESKTVLPFT | 1036 | Q9BX63 | |
| FKGPEFRSRSKMKTE | 141 | P46100 | |
| ATKRKVFEMDPKSLT | 21 | Q6TFL4 | |
| EFSSPKLFTAKMRKL | 131 | Q96BT1 | |
| TLLSPAFTSVKFKEM | 131 | Q9HB55 | |
| NRSSSEPMRKKTKFS | 151 | Q8TD57 | |
| TSIFSPMKKEVKTSL | 181 | Q8TD57 | |
| STDFQKKPRDKMFSS | 91 | Q5T9S5 | |
| QKFTFSIMVPERTAK | 346 | Q6ZTQ4 | |
| SKSFMTTKPADVKET | 1866 | Q8N3K9 | |
| PSSISFKSVEKKMTD | 366 | Q5T5S1 | |
| IFFRKMSSSGAKDKP | 16 | P09543 | |
| TQPKKSISFFATMKA | 61 | Q5VTH9 | |
| AKKRKMFESFIESVP | 246 | P13861 | |
| EDGATMTFFKKSKIS | 686 | Q13002 | |
| ATMTFFKKSKISTFE | 691 | Q13003 | |
| KKPEMFETAIKESTS | 806 | P78347 | |
| STMKASRFVKAFEKD | 1411 | Q9P225 | |
| SMFFHAKPSREIKKS | 196 | Q9BZV2 | |
| SDLTMKTSDKFKFVF | 381 | O00591 | |
| TPMINKTGFKFSAEK | 251 | Q7L1W4 | |
| PSFSAKKMTEKTVKA | 86 | O95997 | |
| MKAFAKSGTPLSFKV | 1881 | Q9P2P1 | |
| DKKKISATSIFFESM | 156 | P34896 | |
| REKSTKKMSPFFGNL | 661 | Q92834 | |
| LKFKSSDPKVTRDQM | 241 | Q96DX7 | |
| MSTPSRFKKDKEIIA | 1 | Q7Z6B7 | |
| RKSMFTFVEKPKVTP | 621 | Q8N3V7 | |
| MSFLFSSRSSKTFKP | 1 | Q9H8S9 | |
| MFPKATDLTFKTKLF | 551 | Q9Y2K3 | |
| TDTTTFKRIFLKRMP | 26 | P00797 | |
| PTTFSLTFKMESARK | 2241 | Q9Y520 | |
| PSFSAKKMTEKTVKA | 86 | Q9NZH4 | |
| PSFSAKKMTEKTVKT | 86 | Q9NZH5 | |
| MKRSFSEFPSRKDSK | 766 | Q15477 | |
| KMTVFPKNKSSTDFS | 321 | O00444 | |
| PVLIKKFSDTSKAFM | 181 | Q5JTH9 | |
| VTTKDSRFKIPKFKM | 2476 | Q8IVF2 | |
| KKTVSFSSMPSEKKI | 91 | Q15111 | |
| EAKRRSTTKPMFTFK | 686 | Q9UMS6 | |
| STTKPMFTFKEPKVS | 691 | Q9UMS6 | |
| GPTFMETASFKKKRS | 156 | Q13009 | |
| KFLKEVKSATPMNTR | 56 | Q96MW7 | |
| SDFKSNISEPTKKVM | 91 | O95073 | |
| ESSKIRAPTTMKKFE | 126 | P08240 | |
| RAPTTMKKFEDSEKA | 131 | P08240 | |
| TKGFRVFKKSMSLPS | 211 | Q9BZD6 | |
| EISKKRNKSFEMSSF | 556 | Q9NQ66 | |
| PELQEKMVSFRSKFK | 361 | P54578 | |
| MRKTFEKKPTATGTF | 1131 | Q5T5U3 | |
| SDFTVPKIRESFMKQ | 651 | Q8IZF0 |